List of works by Patricia Bourguignon

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

scientific article published on 11 May 2015

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

scientific article

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

scientific article published on 14 July 2014

Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine

scientific article published on 03 January 2014

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen

scientific article

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults

scientific article published on August 2013

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

scientific article published on January 2012

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients

scientific article published on 16 September 2014

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study

scientific article published on 19 October 2013

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

scientific article published on 28 January 2016

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

scientific article

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

scientific article published on February 2016

Paulina is supported by:

About Paulina

Help